Get started
Assertio Holdings, Inc.Assertio Holdings, Inc.Assertio Holdings, Inc.

Assertio Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

ASRT chart


Full chart

ASRT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪58.46 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.2264 USD
Net income (FY)
‪−21.58 M‬ USD
Revenue (FY)
‪124.96 M‬ USD
Shares float
‪92.99 M‬
Beta (1Y)
0.95

Employees


Employees (FY)
58
Change (1Y)
+5 +9.43%
Revenue / Employee (1Y)
‪2.15 M‬ USD
Net income / Employee (1Y)
‪−372.09 K‬ USD

About Assertio Holdings, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brendan P. O'Grady
Website
assertiotx.com
Headquarters
Lake Forest
Founded
1995
FIGI
BBG00T442DS2
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ASRT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ASRT highest yielding bonds


ASRT5746402
Assertio Holdings, Inc. 6.5% 01-SEP-2027
Yield to maturity
11.10%
Maturity date
Sep 1, 2027

See all ASRT bonds 


Check out other big names from the same industry as ASRT.

Frequently Asked Questions


The current price of ASRT is 0.6104 USD — it has decreased by −1.72% in the past 24 hours. Watch Assertio Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Assertio Holdings, Inc. stocks are traded under the ticker ASRT.
ASRT stock has risen by 7.09% compared to the previous week, the month change is a −17.51% fall, over the last year Assertio Holdings, Inc. has showed a −24.64% decrease.
We've gathered analysts' opinions on Assertio Holdings, Inc. future price: according to them, ASRT price has a max estimate of 3.50 USD and a min estimate of 1.75 USD. Watch ASRT chart and read a more detailed Assertio Holdings, Inc. stock forecast: see what analysts think of Assertio Holdings, Inc. and suggest that you do with its stocks.
ASRT reached its all-time high on Jul 21, 2015 with the price of 134.9600 USD, and its all-time low was 0.5137 USD and was reached on Apr 9, 2025. View more price dynamics on ASRT chart.
See other stocks reaching their highest and lowest prices.
ASRT stock is 5.64% volatile and has beta coefficient of 0.95. Track Assertio Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Assertio Holdings, Inc. there?
Today Assertio Holdings, Inc. has the market capitalization of ‪58.46 M‬, it has increased by 9.14% over the last week.
Yes, you can track Assertio Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Assertio Holdings, Inc. is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
ASRT earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.044 USD resulting in a −150.00% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Assertio Holdings, Inc. earnings.
Assertio Holdings, Inc. revenue for the last quarter amounts to ‪32.18 M‬ USD, despite the estimated figure of ‪28.67 M‬ USD. In the next quarter, revenue is expected to reach ‪27.52 M‬ USD.
ASRT net income for the last quarter is ‪−10.48 M‬ USD, while the quarter before that showed ‪−2.92 M‬ USD of net income which accounts for −258.64% change. Track more Assertio Holdings, Inc. financial stats to get the full picture.
No, ASRT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 58 employees. See our rating of the largest employees — is Assertio Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Assertio Holdings, Inc. EBITDA is ‪8.98 M‬ USD, and current EBITDA margin is 7.17%. See more stats in Assertio Holdings, Inc. financial statements.
Like other stocks, ASRT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Assertio Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Assertio Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Assertio Holdings, Inc. stock shows the sell signal. See more of Assertio Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.